Related references
Note: Only part of the references are listed.Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs
I. K. Guttilla et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern
Ozlem Darcansoy Iseri et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture
Zhihua An et al.
CANCER LETTERS (2010)
The clinicopathological significance of CD44(+)/CD24(-/low) and CD24(+) tumor cells in invasive micropapillary carcinoma of the breast
Weidong Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Breast cancer chemoresistance: Emerging importance of cancer stem cells
Suebwong Chuthapisith et al.
SURGICAL ONCOLOGY-OXFORD (2010)
Breast cancer stem cells: tools and models to rely on
Emmanuelle Charafe-Jauffret et al.
BMC CANCER (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Identification of CD44v6+/CD24-breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies
Eric L. Snyder et al.
LABORATORY INVESTIGATION (2009)
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass et al.
NATURE GENETICS (2009)
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells
Gerd J. Bauerschmitz et al.
CANCER RESEARCH (2008)
Epithelial mesenchymal transition traits in human breast cancer cell lines
T. Blick et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
Eleni Mylona et al.
HUMAN PATHOLOGY (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Breast cancer stem cells: implications for therapy of breast cancer
Brian J. Morrison et al.
BREAST CANCER RESEARCH (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Tumor growth need not be driven by rare cancer stem cells
Priscilla N. Kelly et al.
SCIENCE (2007)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis
P Baumann et al.
CANCER RESEARCH (2005)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)